In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium
- 1 December 1993
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (12) , 2736-2739
- https://doi.org/10.1128/aac.37.12.2736
Abstract
Sixty strains of vancomycin- and ampicillin-resistant Enterococcus faecium were evaluated for their susceptibilities to novobiocin in vitro. In Mueller-Hinton broth, novobiocin inhibited all strains when it was used at a concentration of < or = 2 microgram/ml and 40 of 60 strains when it was used at a concentration of < or = 0.5 micrograms/ml. MICs were 8- to 16-fold higher in 50% serum. Novobiocin alone resulted in 2-log-unit killing at 24 h. Combinations of novobiocin and a fluoroquinolone (either ciprofloxacin or ofloxacin) were additive and bactericidal for quinolone-susceptible strains in either broth or 50% serum. Gentamicin did not affect novobiocin activity, and rifampin and doxycycline were antagonistic.Keywords
This publication has 18 references indexed in Scilit:
- Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcomeAntimicrobial Agents and Chemotherapy, 1993
- The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding d-Ala:d-Ala ligases and glycopeptide-resistance proteins VanA and VanCGene, 1993
- Increasing resistance of enterococci to ciprofloxacinAntimicrobial Agents and Chemotherapy, 1992
- Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 1992
- Efficacy of short courses of oral novobiocin-rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolatesAntimicrobial Agents and Chemotherapy, 1990
- Should novobiocin be clinically re-evaluated?Diagnostic Microbiology and Infectious Disease, 1989
- In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergyAntimicrobial Agents and Chemotherapy, 1989
- Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combinationAntimicrobial Agents and Chemotherapy, 1986
- Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicinJournal of Antimicrobial Chemotherapy, 1986
- Serious reactions to novobiocinThe Journal of Pediatrics, 1957